Viw Magazine

  • Written by Dimitri Perrin, Senior Lecturer, Queensland University of Technology
The team used CRISPR on human embryos in a bid to render them resistant to HIV infection. But instead, they generated different mutations, about which we know nothing. SHUTTERSTOCK

More than a year ago, the world was shocked by Chinese biophysicist He Jiankui’s attempt to use CRISPR technology to modify human embryos and make them resistant to HIV, which led to the birth of twins Lulu and Nana.

Now, crucial details have been revealed in a recent release of excerpts from the study, which have triggered a series of concerns about how Lulu and Nana’s genome was modified.

How CRISPR works

CRISPR is a technique that allows scientists to make precise edits to any DNA by altering its sequence.

When using CRISPR, you may be trying to “knock out” a gene by rendering it inactive, or trying to achieve specific modifications, such as introducing or removing a desired piece of DNA.


Read more: What is CRISPR gene editing, and how does it work?


Gene editing with the CRISPR system relies on an association of two proteins. One of the proteins, called Cas9, is responsible for “cutting” the DNA. The other protein is a short RNA (ribonucleic acid) molecule which works as a “guide” that brings Cas9 to the position where it is supposed to cut.

The system also needs help from the cells being edited. DNA damage is frequent, so cells regularly have to repair the DNA lesions. The associated repair mechanisms are what introduce the deletions, insertions or modifications when performing gene editing.

How the genomes of Lulu and Nana were modified

Jiankui and his colleagues were targeting a gene called CCR5, which is necessary for the HIV virus to enter into white blood cells (lymphocytes) and infect our body.

One variant of CCR5, called CCR5 Δ32, is missing a particular string of 32 “letters” of DNA code. This variant naturally occurs in the human population, and results in a high level of resistance to the most common type of HIV virus.

Jankui’s team wanted to recreate this mutation using CRISPR on human embryos, in a bid to render them resistant to HIV infection. But this did not go as planned, and there are several ways they may have failed.

First, despite claiming in the abstract of their unpublished article that they reproduced the human CCR5 mutation, in reality the team tried to modify CCR5 close to the Δ32 mutation.

As a result, they generated different mutations, of which the effects are unknown. It may or may not confer HIV resistance, and may or may not have other consequences.

Worryingly, they did not test any of this, and went ahead with implanting the embryos. This is unjustifiable.

The mosaic effect

A second source of errors could have been that the editing was not perfectly efficient. This means that not all cells in the embryos were necessarily edited.

When an organism has a mixture of edited and unedited cells, it is called a “mosaic”. While the available data are still limited, it seems that both Lulu and Nana are mosaic.

This makes it even less likely that the gene-edited babies would be resistant to HIV infection. The risk of mosaicism should have been another reason not to implant the embryos.


Read more: 'Designer' babies won't be common anytime soon – despite recent CRISPR twins


Moreover, editing can have unintended impacts elsewhere in the genome.

When designing a CRISPR experiment, you choose the “guide” RNA so that its sequence is unique to the gene you are targeting. However, “off-target” cuts can still happen elsewhere in the genome, at places that have a similar sequence.

Jiankui and his team tested cells from the edited embryos, and reported only one off-target modification. However, that testing required sampling the cells, which were therefore no longer part of the embryos - which continued developing.

Thus, the remaining cells in the embryos had not been tested, and may have had different off-target modifications.

This is not the team’s fault, as there will always be limitations in detecting off-target and mosaicism, and we can only get a partial picture.

However, that partial picture should have made them pause.

A bad idea to begin

Above, we have described several risks associated with the modifications made on the embryos, which could be passed on to future generations.

Embryo editing is only ethically justifiable in cases where the benefits clearly outweigh the risks.

Technical issues aside, Jiankui’s team did not even address an unmet medical need.

While the twins’ father was HIV-positive, there is already a well-established way to prevent an HIV-positive father from infecting embryos. This “sperm washing” method was actually used by the team.

The only benefit of the attempted gene modification, if proven, would have been a reduced risk of HIV infection for the twins later in life.

But there are safer existing ways to control the risk of infection, such as condoms and mandatory testing of blood donations.

Implications for gene editing as a field

Gene editing has endless applications. It can be used to make plants such as the Cavendish banana more resistant to devastating diseases. It can play an important role in the adaptation to climate change.

In health, we are already seeing promising results with the editing of somatic cells (that is, non-heritable modifications of the patient’s own cells) in beta thalassemia and sickle cell disease.

However, we are just not ready for human embryo editing. Our techniques are not mature enough, and no case has been made for a widespread need that other techniques, such as preimplantation genetic testing, could not address.


Read more: Experts call for halt to CRISPR editing that allows gene changes to pass on to children


There is also much work still needed on governance. There have been individual calls for a moratorium on embryo editing, and expert panels from the World Health Organisation to UNESCO.

Yet, no consensus has emerged.

It is important these discussions move in unison to a second phase, where other stakeholders, such as patient groups, are more broadly consulted (and informed). Engagement with the public is also crucial.

Dimitri Perrin has received funding from the Australian Research Council (ARC), the Australian-French Association for Innovation and Research (AFRAN), and the Advance Queensland programme.

Gaetan Burgio receives funding from the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the National Collaborative Research Infrastructure Strategy (NCRIS) via the Australian Phenomics Network (APN) ,Universities Australia and the Natural Science Foundation in China (NSFC).

Authors: Dimitri Perrin, Senior Lecturer, Queensland University of Technology

Read more http://theconversation.com/chinas-failed-gene-edited-baby-experiment-proves-were-not-ready-for-human-embryo-modification-128454

The Role Of A Construction Supervisor On A Construction Site

Those looking into building a career in the building and construction industry are afforded a lot of options they can pursue, with responsibilities often being as diverse as the projects themsel...

News Company - avatar News Company

4 Writing Hacks You Need to Become a Great Writer

What do you need to mount up your writing skills and become a cooler writer? This venture is highly individual and relies on each particular writer’s personal abilities and expertise. However...

News Company - avatar News Company

Factors to Consider When Looking For Kid’s Birthday Party Venues

Organising huge children's birthday parties begin with finding the right kids birthday party venues. Like every other major activity that requires a bunch of guests, the final venue will dictate...

Ester Adams - avatar Ester Adams

How a Share Registry Works

Australia, the Land Down Under, is a melting pot of cultures, races, and ethnicities. This country embraces diversity and has no tolerance for discrimination of any kind, especially if it is abou...

Ester Adams - avatar Ester Adams

Has Australia really had 60,000 undiagnosed COVID-19 cases?

A preliminary study, posted online this week by researchers at the Australian National University and elsewhere, estimates 71,000 Australians had COVID-19 by mid-July — 60,000 more than official...

Andrew Hayen, Professor of Biostatistics, University of Technology Sydney - avatar Andrew Hayen, Professor of Biostatistics, University of Technology Sydney

How could wearing a mask help build immunity to COVID-19? It’s all about the viral dose

People infected with SARS-CoV-2, the virus that causes COVID-19, can spread the virus when they speak, sing, cough, sneeze or even just breathe. Scientists think face masks help limit virus spread by ...

Larisa Labzin, Research Fellow, Institute for Molecular Bioscience, The University of Queensland - avatar Larisa Labzin, Research Fellow, Institute for Molecular Bioscience, The University of Queensland

the pros and cons of different COVID vaccine technologies

ShutterstockThe World Health Organisation lists about 180 COVID-19 vaccines being developed around the world.Each vaccine aims to use a slightly different approach to prepare your immune system to rec...

Suresh Mahalingam, Principal Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University - avatar Suresh Mahalingam, Principal Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University

Government extends COVID health initiatives at $2 billion cost

The government is extending the COVID health measures for a further six months, until the end of March, in its latest acknowledgement that pandemic assistance will be needed on various fronts for a lo...

Michelle Grattan, Professorial Fellow, University of Canberra - avatar Michelle Grattan, Professorial Fellow, University of Canberra

How to clear Victoria's backlog of elective surgeries after a 6-month slowdown? We need to rethink the system

ShutterstockWith the number of COVID-19 cases in Victoria continuing to trend downwards, Premier Daniel Andrews yesterday announced a phased restart of elective procedures in public and private hospit...

Stephen Duckett, Director, Health Program, Grattan Institute - avatar Stephen Duckett, Director, Health Program, Grattan Institute

Writers Wanted



News Company Media Core

Content & Technology Connecting Global Audiences

More Information - Less Opinion